RESEARCH GOAL
Longevity & Mitochondria
Mitochondrial and aging research without converting biological interest into anti-aging promises.
ASK BETTER QUESTIONS
What changes a longevity & mitochondria evidence decision?
- Is the evidence about an endogenous peptide or a drug product?
- Is any approval limited to a rare disease?
- Are longevity claims supported by human outcomes?
EVIDENCE RECORDS
Longevity & Mitochondria evidence records.
Mitochondrial-derived peptideHuman evidence 1/5
MOTS-c
MOTS-c is biologically interesting, but human physiology observations are frequently mistaken for evidence that an exogenous product improves health or performance.
Open evidence recordSynthetic peptideHuman evidence 3/5
SS-31 / Elamipretide
SS-31 is no longer simply an unapproved research peptide: elamipretide now has one narrow accelerated-approval pathway, with confirmatory evidence still required.
Open evidence recordSynthetic peptideHuman evidence 1/5
Epitalon
Epitalon's longevity narrative is much stronger than its verifiable modern human evidence. The record remains hypothesis-generating, not outcome-proving.
Open evidence recordDIRECT COMPARISONS